1 |
Biological Degradation of Heterocyclic Aromatic Hydrocarbons with Naphthalene-Enriched Consortium: Substrate Interaction Studies and Fate of Metabolites Oberoi AS, Philip L Applied Biochemistry and Biotechnology, 180(3), 400, 2016 |
2 |
Biodegradation of Various Aromatic Compounds by Enriched Bacterial Cultures: Part B-Nitrogen-, Sulfur-, and Oxygen-Containing Heterocyclic Aromatic Compounds Oberoi AS, Philip L, Bhallamudi SM Applied Biochemistry and Biotechnology, 176(6), 1746, 2015 |
3 |
A Fully Defined, Fed-Batch, Recombinant NS0 Culture Process for Monoclonal Antibody Production Hermes PA, Castro CD Biotechnology Progress, 26(5), 1411, 2010 |
4 |
Defined protein and animal component-free NSO fed-batch culture Spens E, Haggstrom L Biotechnology and Bioengineering, 98(6), 1183, 2007 |
5 |
Cholesterol delivery to NSO cells: Challenges and solutions in disposable linear low-density polyethylene-based bioreactors Okonkowski J, Balasubramanian U, Seamans C, Fries S, Zhang J, Salmon P, Robinson D, Chartrain M Journal of Bioscience and Bioengineering, 103(1), 50, 2007 |
6 |
New disposable tubes for rapid and precise biomass assessment for suspension cultures of mammalian cells Stettler M, Jaccard N, Hacker D, De Jesus M, Wurm FM, Jordan M Biotechnology and Bioengineering, 95(6), 1228, 2006 |
7 |
Large-scale gene expression analysis of cholesterol dependence in NSO cells Seth G, Philp RJ, Denoya CD, McGrath K, Stutzman-Engwall KJ, Yap M, Hu WS Biotechnology and Bioengineering, 90(5), 552, 2005 |
8 |
Enhanced growth in NSO cells expressing aminoglycoside phosphotransferase is associated with changes in metabolism, productivity, and apoptosis Veraitch FS, Al-Rubeai M Biotechnology and Bioengineering, 92(5), 589, 2005 |
9 |
Molecular definition of predictive indicators of stable protein expression in recombinant NSO myeloma cells Barnes LM, Bentley CM, Dickson AJ Biotechnology and Bioengineering, 85(2), 115, 2004 |
10 |
Comparative proteomic analysis of GS-NSO murine myeloma cell lines with varying recombinant monoclonal antibody production rate Smales CM, Dinnis DM, Stansfield SH, Alete D, Sage EA, Birch JR, Racher AJ, Marshall CT, James DC Biotechnology and Bioengineering, 88(4), 474, 2004 |